相关实验视频

Updated: Jul 7, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

老年患者中耐药/复发性多发性骨髓瘤的无进展生存效率:系统性审查

Tung-Lung Yang¹, Chin Lin^2,3, Ching-Liang Ho¹

¹Division of Hematology and Oncology Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.

Life (Basel, Switzerland)

|December 23, 2023

概括

达拉图穆马布,莱纳利多米德和德克萨米他 (DaraLenDex) 是对耐火性/复发性多发性骨髓瘤 (R/R MM) 的老年患者最有效的治疗方法. 这种组合疗法为这个脆弱的患者群体提供了更高的无进展生存率.

科学领域:

血液学血液学血液学
在瘤学瘤学.
临床试验临床试验

背景情况:

耐药性/复发性多发性骨髓瘤 (R/R MM) 治疗疗效得到了充分研究,但对老年患者的数据有限.
老年患者可能对强化治疗的抵抗力降低.
对老年R/RMM患者进行有效治疗的评估至关重要.

研究的目的:

评估老年R/RMM患者各种治疗方法的疗效.
为了确定这个特定的人群的最佳组合疗法.

主要方法:

2000年至2022年间发表的随机对照试验 (RCT) 的系统文献综述.
包括来自主要数据库 (PubMed,Embase,Cochrane图书馆) 的13个符合条件的RCT.
使用危险比率 (HR) 进行有效性评估的频率主义网络元分析.

主要成果:

达拉图穆马布,莱纳利多米德和德克萨米他 (DaraLenDex) 的组合显示出更高的疗效.
达拉LenDex显示了无进展生存的有利危险比 (HR) (0.15;95% CI:0.09-0.25).
96%的高P评分进一步支持了DaraLenDex.的疗效.

结论:

DaraLenDex被确定为R/R MM的老年患者最有效的治疗方法.
需要进一步进行全面的RCT来巩固这些发现.
这项研究为优化老年人R/RMM治疗提供了有价值的证据.

关键词:

年长的老人老年人老年人.脆弱的脆弱的脆弱的脆弱耐火和复发的多发性骨髓瘤.

更多相关视频

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...